The bill reduces availability of recreational nitrous-oxide products to lower accidental misuse while preserving necessary medical and food-industry uses, at the cost of lost revenue for some small businesses, added compliance burdens, and the risk that some users may turn to unsafe or illicit alternatives.
Healthcare workers, hospitals, and food-industry businesses — preserved lawful access to nitrous oxide via explicit medical, dental, and food-use exceptions, avoiding disruption to clinical care and food-service operations.
Low-income consumers — reduced availability of nitrous-oxide-containing recreational products, which lowers accidental misuse and related injuries.
Young adults and children — increased risk of switching to unsafe alternatives or illicit markets when legal recreational nitrous oxide is restricted, potentially raising health harms.
Small-business owners (retailers and manufacturers) — loss of legal market access for recreational nitrous-oxide products, reducing sales and income for affected businesses.
Small-business owners, hospitals, and health systems — increased compliance and enforcement costs for the CPSC and regulated entities to identify covered products and document exceptions.
Based on analysis of 2 sections of legislative text.
Classifies consumer products containing nitrous oxide as banned hazardous products under the Consumer Product Safety Act, with specified exceptions for medical, commercial food, and accredited R&D uses.
Bans the sale of consumer products that contain nitrous oxide by adding them to the list of "banned hazardous products" under the Consumer Product Safety Act, with specific exceptions. The prohibition takes effect 180 days after the law is enacted and does not apply to sales for medical or dental treatment, commercial food production (including commercial kitchens and manufacturing), accredited research and development, or food products that use nitrous oxide as a propellant.
Introduced March 16, 2026 by Kevin Mullin · Last progress March 16, 2026